EBOLA FAST DRUG TRIAL METHOD COULD BE USED FOR OTHER EPIDEMICS, SAY EXPERTS
May 1st, 2016
RESEARCHERS have welcomed a new rapid clinical trial system designed to help pharmacos source key efficacy data for medicines focused on fighting an epidemic during rather than after an outbreak. They have been involved in a Wellcome Trust funded trial of the experimental anti-Ebola drug TKM-130803, published in the PLOS Medicine journal. While the medicine did not help patients with advanced Ebola, researchers say data yielded may help prove its effectiveness during earlier stages of the disease. And moreover, the system itself yielded useful information, ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.